L.D. Elving

1.5k total citations
32 papers, 981 citations indexed

About

L.D. Elving is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, L.D. Elving has authored 32 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Nephrology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in L.D. Elving's work include Chronic Kidney Disease and Diabetes (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). L.D. Elving is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). L.D. Elving collaborates with scholars based in Netherlands and Sweden. L.D. Elving's co-authors include Gijs Bleijenberg, Judith B. Prins, Gert Jan van der Wilt, Johan L. Severens, Jos WM van der Meer, Theo M. de Boo, Ellen Bazelmans, Philip Spinhoven, A. F. Casparie and E. de Nobel and has published in prestigious journals such as The Lancet, Diabetes Care and Diabetes.

In The Last Decade

L.D. Elving

30 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.D. Elving Netherlands 14 358 215 184 158 129 32 981
Rebecca Ronsley Canada 15 215 0.6× 161 0.7× 62 0.3× 63 0.4× 58 0.4× 45 650
Ellen L. Connor United States 13 54 0.2× 419 1.9× 154 0.8× 78 0.5× 189 1.5× 20 1.5k
M.J. Harrison United Kingdom 17 231 0.6× 116 0.5× 31 0.2× 34 0.2× 200 1.6× 39 1.3k
Elisabeth Rybo Sweden 10 61 0.2× 475 2.2× 81 0.4× 443 2.8× 144 1.1× 15 1.7k
Angela Galler Germany 24 79 0.2× 763 3.5× 128 0.7× 101 0.6× 364 2.8× 70 1.6k
JAMES P. OʼHARE United Kingdom 19 39 0.1× 290 1.3× 63 0.3× 243 1.5× 142 1.1× 45 1.2k
R Moulias France 20 273 0.8× 64 0.3× 83 0.5× 63 0.4× 60 0.5× 105 1.1k
Rebecca D. Jackson United States 17 82 0.2× 68 0.3× 41 0.2× 48 0.3× 121 0.9× 26 1.1k
A Galvão-Teles Portugal 17 170 0.5× 409 1.9× 95 0.5× 42 0.3× 68 0.5× 34 1.1k
Gilman D. Grave United States 16 77 0.2× 160 0.7× 106 0.6× 169 1.1× 144 1.1× 28 1.3k

Countries citing papers authored by L.D. Elving

Since Specialization
Citations

This map shows the geographic impact of L.D. Elving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.D. Elving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.D. Elving more than expected).

Fields of papers citing papers by L.D. Elving

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.D. Elving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.D. Elving. The network helps show where L.D. Elving may publish in the future.

Co-authorship network of co-authors of L.D. Elving

This figure shows the co-authorship network connecting the top 25 collaborators of L.D. Elving. A scholar is included among the top collaborators of L.D. Elving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.D. Elving. L.D. Elving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Prinsen, Hetty, I. Jolanda M. de Vries, Ruurd Torensma, et al.. (2012). Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome. BMC Immunology. 13(1). 8 indexed citations
3.
Rops, Angelique L., M.J. van den Hoven, B. A. J. Veldman, et al.. (2011). Urinary heparanase activity in patients with Type 1 and Type 2 diabetes. Nephrology Dialysis Transplantation. 27(7). 2853–2861. 39 indexed citations
4.
Adiyaman, Ahmet, et al.. (2007). The effect of crossing legs on blood pressure. Blood Pressure Monitoring. 12(3). 189–193. 13 indexed citations
5.
Peters, Ellen, L.D. Elving, S.J.H. Bredie, et al.. (2005). A brief behavioral feedback intervention in hospital outpatients with a high cardiovascular risk. Patient Education and Counseling. 60(1). 32–40. 18 indexed citations
6.
Bisseling, Tanya M., Alfons C. Wouterse, Eric A.P. Steegers, et al.. (2005). Dysfunction of the cyclo‐oxygenase pathway in the foetoplacental circulation in Type 1 diabetes mellitus. Diabetic Medicine. 22(4). 503–506.
7.
Jacobs, E, et al.. (2005). Impact of the introduction of a guideline on the targeted detection of hereditary haemochromatosis.. PubMed. 63(6). 205–14. 8 indexed citations
8.
Bisseling, Tanya M., Alfons C. Wouterse, Eric A.P. Steegers, et al.. (2003). Nitric Oxide-mediated Vascular Tone in the Fetal Placental Circulation of Patients with Type 1 Diabetes Mellitus. Placenta. 24(10). 974–978. 9 indexed citations
9.
Swinkels, Dorine W., et al.. (2002). Primary haemochromatosis: a missed cause of chronic fatigue syndrome?. PubMed. 60(11). 429–33. 12 indexed citations
10.
Netea, Romana T., L.D. Elving, J. A. Lutterman, & Th. Thien. (2002). Body position and blood pressure measurement in patients with diabetes mellitus. Journal of Internal Medicine. 251(5). 393–399. 28 indexed citations
11.
Galan, Bastiaan E. de, Cees J. Tack, Jacques W.M. Lenders, et al.. (2002). Theophylline Improves Hypoglycemia Unawareness in Type 1 Diabetes. Diabetes. 51(3). 790–796. 45 indexed citations
12.
Prins, Judith B., Gijs Bleijenberg, Ellen Bazelmans, et al.. (2001). Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. The Lancet. 357(9259). 841–847. 396 indexed citations
13.
Elving, L.D., Jack F.M. Wetzels, Henk J.J. van Lier, E. de Nobel, & Jo H. M. Berden. (1994). Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Diabetologia. 37(6). 604–609. 40 indexed citations
14.
Elving, L.D., et al.. (1992). Is increased erythrocyte sodium-lithium countertransport a useful marker for diabetic nephropathy?. Kidney International. 41(4). 862–871. 27 indexed citations
15.
Gruys, E., et al.. (1992). Congenital tremor in Holstein Friesian‐cattle. Veterinary Quarterly. 14(2). 54–56. 4 indexed citations
16.
Elving, L.D., Jack F.M. Wetzels, E. de Nobel, Andries J. Hoitsma, & Jo H. M. Berden. (1992). Captopril Acutely Lowers Albuminuria in Normotensive Patients With Diabetic Nephropathy. American Journal of Kidney Diseases. 20(6). 559–563. 22 indexed citations
17.
Elving, L.D., J F M Wetzels, E. de Nobel, & J. H. M. Berden. (1991). Erythrocyte sodium-lithium countertransport is not different in Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia. 34(2). 126–128. 29 indexed citations
18.
Elving, L.D., et al.. (1989). Screening for microalbuminuria in patients with diabetes mellitus: frozen storage of urine samples decreases their albumin content.. Clinical Chemistry. 35(2). 308–310. 72 indexed citations
19.
Elving, L.D., E. de Nobel, Henk J.J. van Lier, & Th. Thien. (1989). A Comparison of the Hypotensive Effects of Captopril and Atenolol in the Treatment of Hypertension in Diabetic Patients. The Journal of Clinical Pharmacology. 29(4). 316–320. 5 indexed citations
20.
Elving, L.D., et al.. (1978). [Criteria for evaluation of methods, systems and interference procedures to which animals are submitted (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 103(3). 184–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026